{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T05:04:58Z","timestamp":1788671098059,"version":"build-2803163510"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000139","name":"U.S. Environmental Protection Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000139","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.metabol.2021.154706","type":"journal-article","created":{"date-parts":[[2021,1,8]],"date-time":"2021-01-08T12:37:03Z","timestamp":1610109423000},"page":"154706","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"special_numbering":"C","title":["Lipoprotein (a) and coronary artery calcification: prospective study assessing interactions with other risk factors"],"prefix":"10.1016","volume":"116","author":[{"given":"Kwok Leung","family":"Ong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robyn L.","family":"McClelland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew A.","family":"Allison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Cushman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parveen K.","family":"Garg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael Y.","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerry-Anne","family":"Rye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatiha","family":"Tabet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2021.154706_bb0005","doi-asserted-by":"crossref","first-page":"10424","DOI":"10.1021\/bi010556e","article-title":"The structure of lipoprotein(a) and ligand-induced conformational changes","volume":"40","author":"Weisel","year":"2001","journal-title":"Biochemistry."},{"key":"10.1016\/j.metabol.2021.154706_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yjmcc.2019.04.005","article-title":"Biology, pathophysiology and current therapies that affect lipoprotein (a) levels","volume":"131","author":"Rawther","year":"2019","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.metabol.2021.154706_bb0015","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jacc.2017.11.014","article-title":"NHLBI working group recommendations to reduce lipoprotein(a)-mediated risk of cardiovascular disease and aortic stenosis","volume":"71","author":"Tsimikas","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.metabol.2021.154706_bb0020","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1093\/clinchem\/44.11.2301","article-title":"Lipoprotein(a) as a risk factor for ischemic heart disease: metaanalysis of prospective studies","volume":"44","author":"Craig","year":"1998","journal-title":"Clin Chem"},{"key":"10.1016\/j.metabol.2021.154706_bb0025","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1161\/01.CIR.102.10.1082","article-title":"Lipoprotein(a) and coronary heart disease. Meta-analysis of prospective studies","volume":"102","author":"Danesh","year":"2000","journal-title":"Circulation."},{"key":"10.1016\/j.metabol.2021.154706_bb0030","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1001\/jama.2009.1063","article-title":"Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality","volume":"302","author":"Erqou","year":"2009","journal-title":"JAMA."},{"key":"10.1016\/j.metabol.2021.154706_bb0035","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.atherosclerosis.2015.08.021","article-title":"Lipoprotein (a) as a risk factor for ischemic stroke: a meta-analysis","volume":"242","author":"Nave","year":"2015","journal-title":"Atherosclerosis."},{"key":"10.1016\/j.metabol.2021.154706_bb0040","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1373\/clinchem.2016.270751","article-title":"Evaluation of lipoprotein(a) electrophoretic and immunoassay methods in discriminating risk of calcific aortic valve disease and incident coronary heart disease: the Multi-Ethnic Study of Atherosclerosis","volume":"63","author":"Cao","year":"2017","journal-title":"Clin Chem"},{"key":"10.1016\/j.metabol.2021.154706_bb0045","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ejim.2012.08.014","article-title":"Lipoprotein (a) is independently correlated with coronary artery calcification","volume":"24","author":"Greif","year":"2013","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.metabol.2021.154706_bb0050","article-title":"Lipoprotein (a) and risk for calcification of the coronary arteries, mitral valve, and thoracic aorta: the Multi-Ethnic Study of Atherosclerosis","volume":"21","author":"Garg","year":"2020","journal-title":"J Cardiovasc Comput Tomogr"},{"key":"10.1016\/j.metabol.2021.154706_bb0055","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.jcmg.2017.04.018","article-title":"Coronary artery calcium volume and density: potential interactions and overall predictive value: the Multi-Ethnic Study of Atherosclerosis","volume":"10","author":"Criqui","year":"2017","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.metabol.2021.154706_bb0060","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1001\/jama.2013.282535","article-title":"Calcium density of coronary artery plaque and risk of incident cardiovascular events","volume":"311","author":"Criqui","year":"2014","journal-title":"JAMA."},{"key":"10.1016\/j.metabol.2021.154706_bb0065","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1161\/CIRCULATIONAHA.107.743161","article-title":"Vascular calcification: pathobiology of a multifaceted disease","volume":"117","author":"Demer","year":"2008","journal-title":"Circulation."},{"key":"10.1016\/j.metabol.2021.154706_bb0070","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.atherosclerosis.2008.05.039","article-title":"Elevated fibrinogen levels and subsequent subclinical atherosclerosis: the CARDIA study","volume":"202","author":"Green","year":"2009","journal-title":"Atherosclerosis."},{"key":"10.1016\/j.metabol.2021.154706_bb0075","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.jcmg.2011.12.015","article-title":"Metabolic syndrome, diabetes, and incidence and progression of coronary calcium: the Multiethnic Study of Atherosclerosis study","volume":"5","author":"Wong","year":"2012","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.metabol.2021.154706_bb0080","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1093\/aje\/kwf113","article-title":"Multi-Ethnic Study of Atherosclerosis: objectives and design","volume":"156","author":"Bild","year":"2002","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.metabol.2021.154706_bb0085","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1161\/ATVBAHA.118.311220","article-title":"Lp(a) [lipoprotein(a)]-related risk of heart failure is evident in whites but not in other racial\/ethnic groups","volume":"38","author":"Steffen","year":"2018","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.metabol.2021.154706_bb0090","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1161\/ATVBAHA.118.312267","article-title":"Race-based differences in lipoprotein(a)-associated risk of carotid atherosclerosis","volume":"39","author":"Steffen","year":"2019","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.metabol.2021.154706_bb0095","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1093\/clinchem\/46.12.1956","article-title":"Use of a reference material proposed by the International Federation of Clinical Chemistry and Laboratory Medicine to evaluate analytical methods for the determination of plasma lipoprotein(a)","volume":"46","author":"Marcovina","year":"2000","journal-title":"Clin Chem"},{"key":"10.1016\/j.metabol.2021.154706_bb0100","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1148\/radiol.2341040439","article-title":"Calcified coronary artery plaque measurement with cardiac CT in population-based studies: standardized protocol of Multi-Ethnic Study of Atherosclerosis (MESA) and Coronary Artery Risk Development in Young Adults (CARDIA) study","volume":"234","author":"Carr","year":"2005","journal-title":"Radiology."},{"key":"10.1016\/j.metabol.2021.154706_bb0105","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.2337\/diacare.27.6.1487","article-title":"Use and abuse of HOMA modeling","volume":"27","author":"Wallace","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2021.154706_bb0110","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.metabol.2021.154706_bb0115","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1161\/ATVBAHA.114.304785","article-title":"Race is a key variable in assigning lipoprotein(a) cutoff values for coronary heart disease risk assessment: the Multi-Ethnic Study of Atherosclerosis","volume":"35","author":"Guan","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.metabol.2021.154706_bb0120","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ahj.2017.11.010","article-title":"Association of lipoprotein-associated phospholipase A(2) and risk of incident atrial fibrillation: findings from 3 cohorts","volume":"197","author":"Garg","year":"2018","journal-title":"Am Heart J"},{"key":"10.1016\/j.metabol.2021.154706_bb0125","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.psyneuen.2011.11.009","article-title":"Associations of salivary cortisol levels with inflammatory markers: the Multi-Ethnic Study of Atherosclerosis","volume":"37","author":"DeSantis","year":"2012","journal-title":"Psychoneuroendocrinology."},{"key":"10.1016\/j.metabol.2021.154706_bb0130","first-page":"391","article-title":"Biomarkers of inflammation and hemostasis associated with left ventricular mass: the multiethnic study of atherosclerosis (MESA)","volume":"2","author":"Arnett","year":"2011","journal-title":"Int J Mol Epidemiol Genet"},{"key":"10.1016\/j.metabol.2021.154706_bb0135","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1681\/ASN.2018070719","article-title":"Association of Soluble TNFR-1 concentrations with long-term decline in kidney function: the Multi-Ethnic Study of Atherosclerosis","volume":"29","author":"Bhatraju","year":"2018","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.metabol.2021.154706_bb0140","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1136\/heartjnl-2014-306649","article-title":"Association between anti-human heat shock protein-60 and interleukin-2 with coronary artery calcium score","volume":"101","author":"Damluji","year":"2015","journal-title":"Heart."},{"key":"10.1016\/j.metabol.2021.154706_bb0145","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.hlc.2018.03.007","article-title":"Homocysteine and incident atrial fibrillation: the atherosclerosis risk in communities study and the Multi-Ethnic Study of Atherosclerosis","volume":"28","author":"Kubota","year":"2019","journal-title":"Heart Lung Circ"},{"key":"10.1016\/j.metabol.2021.154706_bb0150","first-page":"1263","article-title":"2016 Canadian cardiovascular society guidelines for the management of dyslipidemia for the prevention of cardiovascular disease in the adult","volume":"32","author":"Anderson","year":"2016","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.metabol.2021.154706_bb0155","first-page":"e1082","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the Management of Blood Cholesterol: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"139","author":"Grundy","year":"2019","journal-title":"Circulation."},{"key":"10.1016\/j.metabol.2021.154706_bb0160","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1001\/jama.2009.801","article-title":"Genetically elevated lipoprotein(a) and increased risk of myocardial infarction","volume":"301","author":"Kamstrup","year":"2009","journal-title":"JAMA."},{"key":"10.1016\/j.metabol.2021.154706_bb0165","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s11886-019-1182-0","article-title":"Lp(a): addressing a target for cardiovascular disease prevention","volume":"21","author":"Vasquez","year":"2019","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/j.metabol.2021.154706_bb0170","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ijcard.2016.07.219","article-title":"Increased risk of coronary artery calcification progression in subjects with high baseline Lp(a) levels: the Kangbuk Samsung Health Study","volume":"222","author":"Cho","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.metabol.2021.154706_bb0175","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.jacl.2018.02.007","article-title":"Elevated lipoprotein(a) levels are associated with coronary artery calcium scores in asymptomatic individuals with a family history of premature atherosclerotic cardiovascular disease","volume":"12","author":"Verweij","year":"2018","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.metabol.2021.154706_bb0180","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1161\/ATVBAHA.118.311857","article-title":"Lipoprotein(a) and risk of ischemic stroke in the REGARDS study","volume":"39","author":"Arora","year":"2019","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.metabol.2021.154706_bb0185","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1373\/clinchem.2010.146779","article-title":"Lipoprotein(a) and risk of type 2 diabetes","volume":"56","author":"Mora","year":"2010","journal-title":"Clin Chem"},{"key":"10.1016\/j.metabol.2021.154706_bb0190","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1194\/jlr.P049015","article-title":"Serum lipoprotein (a) concentrations are inversely associated with T2D, prediabetes, and insulin resistance in a middle-aged and elderly Chinese population","volume":"56","author":"Ding","year":"2015","journal-title":"J Lipid Res"},{"key":"10.1016\/j.metabol.2021.154706_bb0195","doi-asserted-by":"crossref","first-page":"S113","DOI":"10.33549\/physiolres.933583","article-title":"Inverse association of lipoprotein (a) with markers of insulin resistance in dyslipidemic subjects","volume":"66","author":"Vaverkov\u00e1","year":"2017","journal-title":"Physiol Res"},{"key":"10.1016\/j.metabol.2021.154706_bb0200","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0021-9150(93)90117-D","article-title":"Plasma triglycerides and lipoprotein(a): inverse relationship in a hyperlipidemic Italian population","volume":"101","author":"Werba","year":"1993","journal-title":"Atherosclerosis."},{"key":"10.1016\/j.metabol.2021.154706_bb0205","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S2213-8587(13)70064-0","article-title":"Lipoprotein(a) concentrations, isoform size, and risk of type 2 diabetes: a Mendelian randomisation study","volume":"1","author":"Kamstrup","year":"2013","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.metabol.2021.154706_bb0210","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1161\/CIRCRESAHA.117.311312","article-title":"Cardiovascular event prediction by machine learning: the Multi-Ethnic Study of Atherosclerosis","volume":"121","author":"Ambale-Venkatesh","year":"2017","journal-title":"Circ Res"},{"key":"10.1016\/j.metabol.2021.154706_bb0215","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.ijcard.2011.11.034","article-title":"Association of novel biomarkers with future cardiovascular events is influenced by ethnicity: results from a multi-ethnic cohort","volume":"166","author":"Veeranna","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.metabol.2021.154706_bb0220","first-page":"2236","article-title":"A rapid colorimetric sensor for soluble Interleukin-2 receptor \u03b1","volume":"20","author":"Jeon","year":"2019","journal-title":"Based on Aptamer-Adsorbed AuNP Chembiochem"},{"key":"10.1016\/j.metabol.2021.154706_bb0225","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.biocel.2005.09.015","article-title":"Soluble interleukin-2 receptor as a marker for progression of coronary artery calcification in type 1 diabetes","volume":"38","author":"Wadwa","year":"2006","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.metabol.2021.154706_bb0230","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.cca.2013.10.011","article-title":"Association of serum IgG4 and soluble interleukin-2 receptor levels with epicardial adipose tissue and coronary artery calcification","volume":"428","author":"Sakamoto","year":"2014","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.metabol.2021.154706_bb0235","doi-asserted-by":"crossref","first-page":"4845","DOI":"10.1073\/pnas.89.11.4845","article-title":"Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo","volume":"89","author":"Van Zee","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.metabol.2021.154706_bb0240","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1161\/ATVBAHA.107.153668","article-title":"Aortic Msx2-Wnt calcification cascade is regulated by TNF-alpha-dependent signals in diabetic Ldlr\u2212\/\u2212 mice","volume":"27","author":"Al-Aly","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.metabol.2021.154706_bb0245","doi-asserted-by":"crossref","first-page":"3897","DOI":"10.1210\/en.2012-1216","article-title":"TNFR1-activated reactive oxidative species signals up-regulate osteogenic Msx2 programs in aortic myofibroblasts","volume":"153","author":"Lai","year":"2012","journal-title":"Endocrinology."},{"key":"10.1016\/j.metabol.2021.154706_bb0250","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0143686","article-title":"Simvastatin attenuates oxidative stress, NF-\u03baB activation, and artery calcification in LDLR\u2212\/\u2212 mice fed with high fat diet via down-regulation of tumor necrosis factor-\u03b1 and TNF receptor 1","volume":"10","author":"Lin","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.metabol.2021.154706_bb0255","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/rth2.12191","article-title":"Fibrinogen and fibrin: an illustrated review","volume":"3","author":"Pieters","year":"2019","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.metabol.2021.154706_bb0260","first-page":"1613","article-title":"Lipoprotein(a), fibrinogen and vascular mortality in an elderly northern Italian population","volume":"91","author":"D\u2019Angelo","year":"2006","journal-title":"Haematologica."},{"key":"10.1016\/j.metabol.2021.154706_bb0265","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1194\/jlr.P094763","article-title":"Potent reduction of plasma lipoprotein (a) with an antisense oligonucleotide in human subjects does not affect ex vivo fibrinolysis","volume":"60","author":"Boffa","year":"2019","journal-title":"J Lipid Res"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049521000068?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049521000068?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T04:26:37Z","timestamp":1758428797000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049521000068"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":53,"alternative-id":["S0026049521000068"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2021.154706","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lipoprotein (a) and coronary artery calcification: prospective study assessing interactions with other risk factors","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2021.154706","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"154706"}}